PROAIR DIGIHALER
Albuterol sulfate · Teva Pharmaceuticals
US distribution discontinued
Teva discontinued US distribution of all Digihaler products effective June 1, 2024; the companion app and dashboard are no longer available. Existing inhalers may be used until expiration.
Teva Digihaler discontinuation noticeActive Medication & Mechanism
- Albuterol sulfate SABA90 mcg albuterol per inhalation
Short-acting beta2-adrenergic agonist. Activates beta2-receptors on airway smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation (onset 5–15 minutes, duration 4–6 hours).
FDA-Approved Dosing — Strength × Indication
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
Rescue inhaler. Indicated for acute bronchospasm and as-needed symptom relief — onset within minutes. Increasing or frequent use signals worsening asthma control and warrants controller therapy reassessment.
Related Inhalers
Same active ingredients (Albuterol)
Other SABA inhalers